Sponsor:
University of Maryland, Baltimore
Code:
NCT04843852
Conditions
Hepatitis B
Chronic Hepatitis B
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-03. This information was provided to ClinicalTrials.gov by University of Maryland, Baltimore on 2025-10-20.